Medwave

Medwave, Inc. was a medical technology company primarily focused on the development and commercialization of non-invasive blood pressure monitoring systems. The company's flagship technology, Vasotrax, utilized a proprietary sensor-based approach to provide continuous, beat-to-beat blood pressure measurements without the need for an invasive arterial line. This technology was designed for use in critical care settings, such as operating rooms and intensive care units, where accurate and frequent monitoring is essential. Medwave was publicly traded on the NASDAQ under the symbol MDWV before being acquired by GE Healthcare in 2007.